MELANOMA (SKIN)
Clinical trials for MELANOMA (SKIN) explained in plain language.
Never miss a new study
Get alerted when new MELANOMA (SKIN) trials appear
Sign up with your email to follow new studies for MELANOMA (SKIN), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New vaccine combo shows promise in advanced skin cancer trial
Disease control OngoingThis study tests two experimental cancer vaccines, SCIB1 and iSCIB1+, when added to standard immunotherapy drugs (nivolumab with ipilimumab or pembrolizumab) for people with advanced melanoma that cannot be removed by surgery. The goal is to see if the vaccines are safe and can i…
Matched conditions: MELANOMA (SKIN)
Phase: PHASE2 • Sponsor: Scancell Ltd • Aim: Disease control
Last updated May 17, 2026 05:44 UTC
-
Smart drug schedule shows promise for tough skin cancer
Disease control OngoingThis early study tested a new way of giving three drugs (encorafenib, binimetinib, and nivolumab) to people with advanced BRAF-mutant melanoma. Instead of taking the drugs every day, participants followed an on/off schedule to see if it could control the cancer while reducing sid…
Matched conditions: MELANOMA (SKIN)
Phase: EARLY_PHASE1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
Can a 4-Week drug course keep melanoma from coming back?
Disease control OngoingThis study looked at whether giving a high dose of the drug interferon alfa-2b for four weeks can help prevent melanoma from returning after it has been completely removed by surgery. About 1,150 people with stage II or III melanoma took part. Half received the drug, and half wer…
Matched conditions: MELANOMA (SKIN)
Phase: PHASE3 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated May 04, 2026 16:21 UTC